Emerging Infectious Disease ISSN: 1080-6059

Vibrio cholerae O139 in Calcutta, 1992-1998: Incidence, Antibiograms, and Genotypes

Arnab Basu*, Pallavi Garg*, Simanti Datta*, Soumen Chakraborty*, Tanuja Bhattacharya*, Asis Khan*, T. Ramamurthy*, S.K. Bhattacharya*, Shinji Yamasaki†, Yoshifumi Takeda‡, and G. Balakrish Nair*

Author affiliations: *National Institute of Cholera and Enteric Diseases, Calcutta, India; †International Medical Center of Japan, Tokyo, Japan; and ‡National Institute of Infectious Diseases, Tokyo, Japan

Main Article

Figure 3

Antibiotic resistance pattern of the V. cholerae O139 strains. Abbreviations: A, ampicillin; C, chloramphenicol; Cf, ciprofloxacin; Co, cotrimoxazole; Fz, furazolidone; G, gentamycin; N, neomycin; Na, nalidixic acid; Nx, norfloxacin; S, streptomycin; T, tetracycline.

Figure 3. Antibiotic resistance pattern of the V. cholerae O139 strains. Abbreviations: A, ampicillin; C, chloramphenicol; Cf, ciprofloxacin; Co, cotrimoxazole; Fz, furazolidone; G, gentamycin; N, neomycin; Na, nalidixic acid; Nx, norfloxacin; S, streptomycin; T, tetracycline.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.